Interleukin-1 receptor antagonist gene polymorphism in Taiwanese patients with gout

Clinical and Experimental Rheumatology

Volumn 23, Issue 1, 2005, Pages 85-88

  Lo, Sui Foon ^a   Huang, Chung Ming ^a   Tsai, Chang Hai ^b   Chen, Man Ling ^a   Tsai, Fuu Jen ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b ASIA UNIVERSITY   (Taiwan)

Author keywords

Gene polymorphism; Gout; IL 1 receptor antagonist

Indexed keywords

GENOMIC DNA; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC MARKER; GENOTYPE; GOUT; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TAIWAN;

FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GOUT; HETEROZYGOTE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; POLYMORPHISM, GENETIC; SIALOGLYCOPROTEINS; TAIWAN;

EID: 15844374124     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. SIMKIN PA: Towards a coherent terminology of gout. Ann Rheum Dis 1993; 52: 693-4.
2. MADDISON PJ, ISENBERG DA, WOO P, GLASS DN: Crystal arthropathies. In Oxford Textbook of Rheumatology, 2nd ed., New York, Oxford University Press, 1998: 1555-81.
3. SEEGMILLER JD, HOWELL RR, MALAWISTA SE: Inflammatory reaction to sodium urate: its possible relationship to the genesis of acute gouty arthritis. JAMA 1962; 180: 469-76.
4. PASCUAL E: Persistence of monosodium urate crystals and low-grade inflammation in the synovial fluid of patients with untreated gout. Arthritis Rheum 1991; 34: 141-5.
5. DiGIOVINE FS et al.: Interleukin 1 (IL-1) as a mediator of crystal arthritis. Stimulation of T cell and synovial fibroblast mitogenesis by urate crystal induced IL1. J Immunol 1987; 138: 3213-8.
6. CARPENTER LR, YANCOPOULOS GD, STAHL N: General mechanisms of cytokine receptor signaling. Adv Protein Chem 1998; 52: 109-40.
7. RUBINSTEIN M, DINARELLO CA, OPPENHEIM JJ, HERTZOG P: Recent advances in cytokines, cytokine receptors and signal transduction. Cytokine Growth F R 1998; 9: 175-81.
8. IHLE JN, THIERFELDER W, TEGLUND S et al.: Signaling by the cytokine receptor superfamily. Ann NY Acad Sci 1998; 865: 1-9.
9. EISENBERG SP, EVANS RJ, AREND WP et al.: Primary structure and functional expression from complementary DNA of a human interleukin 1 receptor antagonist. Nature 1990; 343: 341-6.
10. AREND WP: Interleukin 1 receptor antagonist: a new member of the interleukin-1 family. J Clin Invest 1991; 88: 1445-51.
11. DINARELLO CA, THOMSON G: Blocking IL-1: Interleukin 1 receptor antagonist in vivo and in vitro. Immunol Today 1991; 12: 404-10.
12. CLAY FE, CORK MJ, TARLOW JK et al.: Interleukin 1 receptor antagonist gene polymorphism association with lichen sclerosis. Hum Genet 1994; 94: 407-10.
13. BLAKEMORE AIF, TARLOW JK, CORK MJ, GORDON C, EMERY P, DUFF GW: Interleukin 1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum 1994; 37: 1380-5.
14. TARLOW JK, CORK MJ, CLAY FE, SCHMITTEGENOLF M, CRANE AM, STIERIE C et al.: Association between interleukin-1 receptor antagonist gene polymorphism and early and late-onset psoriasis. Br J Dermatol 1997; 136: 147-8.
15. MANSFIELD JC, HOLDEN H, TARLOW JK et al.: Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 1994; 106: 637-42.
16. HUANG CM, WU MC, WU JY, TSAI FJ: Interleukin-1 receptor antagonist gene polymorphism in Chinese patients with systemic lupus erythematosus. Clin Rheumatol 2002; 21: 255-7.
17. NICKLIN MJH, WEITH A, DUFF GW: A physical map of the region encompassing the human interleukin-1α,β and the interleukin-1 receptor antagonist genes. Genomics 1994; 19: 382-4.
18. TARLOW JK, BLAKEMORE AI, LENNARD A et al.: Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 1993; 403-4.
19. WALLACE SL et al.: Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977; 20: 895-900.
20. BIDWELL J, KEEN L, GALLAGHER G et al.: Cytokine gene polymorphism in human disease: on-line databases. Genes Immun 1999; 1: 3-19.
21. ELOMAR EM, CARRINGTON M, CHOW WH et al.: Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404: 398-402.
22. MIOSSEC P, DINARELLO CA, ZIFF M: Interleukin-1-lymphocyte chemotactic activity in rheumatoid arthritis synovial fluid. Arthritis Rheum 1986; 29: 461-70.
23. NOURI A, PANAYI GS, GOODMAN SM: Cytokines and the chronic inflammation of rheumatic disease. I. The presence of interleukin-1 in synovial fluids. Clin Exp Immunol 1984; 55: 259-302.
24. HASKILL JS, MARTIN G, Van LE L et al.: cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium. Proc Natl Acad Sci USA 1991; 88: 3681-5.
25. PERRIER S, COUSSEDIERE C, DBOST JJ et al.: IL-1 receptor antagonist gene polymorphism in Sjögren's syndrome and rheumatoid arthritis. Clin Immunol Immunopathol 1998; 87: 309-13.
26. McGARRY F, NEILLY J, ANDERSON N et al.: A polymorphism within the interleukin 1 receptor antagonist gene is associated with ankylosing spondylitis. Rheumatology 2001; 40: 1359-64.
27. BARRERA P, FAURE S, PRUD'HOMME JF et al.: European genetic study on rheumatoid arthritis: Is there a linkage of the interleukin-1 (IL-1),IL-10 or IL-4 genes to RA? Clin Exp Rheumatol 2001; 19: 709-14.
28. LEE YH, KIM HJ, RHO YH, CHOI SJ, JI JD, SONG GG: Interleukin-1 receptor antagonist gene polymorphism and rheumatoid arthritis. Rheumatol Int 2004; 24: 133-6.
29. DANIS VA, MILLINGTON M, HLAND VJ, GRENAN D: Cytokine production by monocytes: Intersubject variation and relationship to an IL-1ra gene polymorphism. Clin Exp Immunol 1995; 99: 303-10.
30. WILKINSON RJ, PATEL P, LLEWELYN M et al.: Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1β on tuberculosis. J Exp Med 1999; 189: 1863-73.
31. CARTER MS, JONES S, DiGIOVINE FS, CAMP NJ, LOBO AI, DUFF GW: Allele 2 of IL-1ra gene polymorphism is associated with reduced expression of IL-1Ra in ulcerative colitis. Gastroenterology 1998; 114: G3882 abstract.
32. DEWBERRY R, HOLDEN H, CROSSMAN D, FRANCIS S: Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis. Arterioscler Thromb Vasc Biol 2000; 20: 2394-400.
33. ROUBENOFF R, KLAG MJ, MEAD LA, LIANG KY, SEIDLER AJ, HOCHBERG MC: Incidence and risk factors for gout in white men. JAMA 1991; 266: 3004-7.
34. ABBOTT RD. BTAND FN, KANNEL WB & CASTELLI WP: Gout and coronary artery disease: the Framingham Study. J Clin Epidemiol 1988; 41: 237-42.
35. SCOTT JT: Obesity and hyperuricemia. Clin Rheum Dis 1977; 3: 23-35.